Recurrent MiscarriageOBPORPLNCT06356792
Obstetrics , Prenatal Outcomes in Recurrent Miscarriage
An observational study of Recurrent Miscarriage, run by Assiut University at 1 site in Egypt.
Trial summary
The effect of recurrent miscarriage on the outcome of the current pregnancy and if there's a relation between it and adverse out come Read more about this study
- Who is it for?
- Ages 17 years and older, women onlyHealthy volunteers can take part
- Conditions the study is for
- Recurrent Miscarriage
- How many people
- 102 participants
- Where
- 1 siteEgypt
- Study dates
- 21 Apr 2024to 21 Mar 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 17 years and older
- Women only
- Healthy volunteers accepted
- Child, Adult, Older adult
Study population: patients who had ≥2 abortions during early pregnancy, patients had no abnormal reproductive tract anatomy , single fetus
Who may be able to join
- 1- patients who had ≥2 abortions during early pregnancy 2.patients had no abnormal reproductive tract anatomy 3. Pregnant in single fetus
Who cannot join
- chronic hypertension, chronic kidney diseases autoimmune diseases multiple pregnancy
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Associations Between History of Recurrent Miscarriage and Obstetric and Perinatal Outcomes in the Subsequent Pregnancy
The effect of recurrent miscarriage on the outcome of the current pregnancy and if there's a relation between it and adverse out come
- Conditions
- Recurrent Miscarriage
- Medical subject headings
- Abortion, Habitual
What is being measured
The primary outcome is the main question the study is designed to answer.
If there's relation between recurrent abortion and having a medical disorder during current pregnancy
Measured: 2023 to 2025
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Apr 2024
- Study start21 Apr 2024 (estimated)
- Primary completion21 Mar 2025 (estimated)
- Study completion21 Mar 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Recurrent MiscarriageStudies of the same condition, open and under way.
- More trials run by Assiut UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Other
- Enrolment
- 102 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Assiut University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Reem Salah Abdelkareem Ahmed, Assiut University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06356792
- Sponsor's protocol ID
- Obstetrics outcome in Abortion
- Acronym
- OBPORPL
- Status last verified
- Apr 2024
- First submitted
- 21 Mar 2024
- Last updated
- 10 Apr 2024
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 10 Apr 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Associations Between History of Recurrent Miscarriage and Obstetric and Perinatal Outcomes in the Subsequent Pregnancy
- ClinicalTrials.gov ID
- NCT06356792
- Acronym / sponsor ID
- OBPORPL / Obstetrics outcome in Abortion
- Conditions
- Recurrent Miscarriage
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 102 participants (estimated)
- Lead sponsor
- Assiut UniversityUniversity, hospital or other
- Study start
- 21 Apr 2024 (estimated)
- Primary completion
- 21 Mar 2025 (estimated)
- Study completion
- 21 Mar 2025 (estimated)
- First posted
- 10 Apr 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The effect of recurrent miscarriage on the outcome of the current pregnancy and if there's a relation between it and adverse out come
Study design
- Observational model
- Cohort
- Time perspective
- Other
Who may qualify
- Ages
- 17 years and older
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
- Study population
- patients who had ≥2 abortions during early pregnancy, patients had no abnormal reproductive tract anatomy , single fetus
Key inclusion criteria (1 listed)
- 1- patients who had ≥2 abortions during early pregnancy 2.patients had no abnormal reproductive tract anatomy 3. Pregnant in single fetus
Key exclusion criteria (1 listed)
- chronic hypertension, chronic kidney diseases autoimmune diseases multiple pregnancy
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
If there's relation between recurrent abortion and having a medical disorder during current pregnancy
Time frame: 2023 to 2025
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Apr 2024.
Related trials for Recurrent Miscarriage
Not yet recruitingPhase 3
Efficacy of Progesterone and Low Molecular Weight Heparin in Recurrent Pregnancy Loss
Pregnancy Loss, Pregnancy Loss, Early
Not yet recruitingPhase 4
Azithromycin for Cerclage Prophylaxis
Cervical Insufficiency
Not yet recruiting
Personalized Care for Prenatal Stress Reduction & Prevention of Preterm Birth (PTB) Disparities
Preterm Birth Complication, Preterm Birth
Not yet recruitingObservational study
Cohort Study on the Levels of Placental Growth Factor and Nucleosomes in Early Pregnancy and Adverse Pregnancy Outcomes
Preeclampsia, Premature Birth
RecruitingPhase 2
Efficacy of Recombinant Human G-CSF in Women With Unexplained Recurrent Miscarriage
Recurrent Pregnancy Loss, Recurrent Miscarriages
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Recurrent Miscarriage, run by Assiut University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 10 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Reem Salah Abdelkareem, Master (01279438766, Reemsalah246@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
If there's relation between recurrent abortion and having a medical disorder during current pregnancy (time frame: 2023 to 2025). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Apr 2024.